Physician profile
Michael M Chen
NPI 1730686296
$1,898.01
in general payments reported to CMS, 2019-2025
16 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.81 · 2022: $562 · 2023: $716 · 2024: $482 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,306.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $495.68 | 2022-2023 | Eliquis |
| Kestra Medical Technology Services, INC. | $249.13 | 2023-2024 | Assure Wcd |
| Astrazeneca Pharmaceuticals Lp | $222.26 | 2022-2023 | Brilinta, Farxiga |
| Medtronic, INC. | $155.68 | 2023-2025 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Penumbra, INC. | $130.85 | 2024 | Indigo System |
| Lexicon Pharmaceuticals, INC. | $121.95 | 2023-2024 | Inpefa |
| Ethicon US, LLC | $116.71 | 2023-2025 | Echelon Circular, Vistaseal |
| Pfizer INC. | $97.36 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $91.21 | 2022 | |
| Janssen Pharmaceuticals, INC | $75.00 | 2023 | Xarelto |
| Scpharmaceuticals INC. | $49.94 | 2024-2025 | |
| Mylan Specialty L.P. | $28.81 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.20 | 2025 | Lifevest |
| Boston Scientific Corporation | $19.04 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $16.49 | 2023 | Caldolor |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $4.70 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.